Baillie Gifford's position in Insulet is currently worth $740M. That's 0.53% of their equity portfolio (35th largest holding). The investor owns 3.09% of the outstanding Insulet stock. Baillie Gifford started to build up the position in Insulet in Q4 2023 and continued to invest until Q4 2024. Since then they sold 221k shares. The stake costed the investor $391M, netting the investor a gain of 89% so far.